https://www.provenconnect.com/good-to-know/unmet-need-call-prostate-specific-antigen-psa-monitoring/2022-11-17T16:56:36+00:00https://www.provenconnect.com/good-to-know/introducing-proven-connect-a-new-translational-programme-for-pcr/2022-11-17T19:48:41+00:00https://www.provenconnect.com/good-to-know/stratosvir/2024-06-20T12:06:32+01:00https://www.provenconnect.com/good-to-know/prostate-cancer-research-ukri-investment-partnership-announced/2024-03-14T14:29:42+00:00https://www.provenconnect.com/good-to-know/new-member/2024-06-20T11:59:38+01:00https://www.provenconnect.com/good-to-know/academics-clinicians-and-industry/2024-05-15T10:52:17+01:00https://www.provenconnect.com/good-to-know/proven-connect-launches-1m-philanthropic-fund/2024-11-27T12:27:34+00:00https://www.provenconnect.com/good-to-know/new-investment-into-oxford-vacmedix/2024-11-27T11:14:41+00:00https://www.provenconnect.com/good-to-know/pcr-launches-landmark-report-into-the-socio-economic-impact-of-prostate-cancer-screening/2024-11-27T12:11:40+00:00https://www.provenconnect.com/good-to-know/the-bob-willis-fund-supports-innovation-for-earlier-prostate-cancer-diagnosis/2025-06-03T11:36:08+01:00https://www.provenconnect.com/good-to-know/we-welcome-3-new-members-to-our-translational-scientific-advisory-committee/2025-06-03T11:28:46+01:00https://www.provenconnect.com/good-to-know/pcr-prioritises-accelerating-innovation-for-prostate-cancer-patients/2025-07-02T15:34:49+01:00https://www.provenconnect.com/good-to-know/meet-franco/2025-08-06T09:13:02+01:00https://www.provenconnect.com/good-to-know/tar-website-launches/2025-12-11T15:18:47+00:00https://www.provenconnect.com/good-to-know/meet-celine-kowalska/2026-02-13T11:43:52+00:00https://www.provenconnect.com/good-to-know/pcrs-5-year-investment-journey/2026-07-31T10:20:57+01:00